US 11,938,015 B2
Bioprinted tissue with therapy capability
Sarbajit K. Rakshit, Kolkata (IN)
Assigned to International Business Machines Corporation, Armonk, NY (US)
Filed by International Business Machines Corporation, Armonk, NY (US)
Filed on May 21, 2020, as Appl. No. 16/879,973.
Prior Publication US 2021/0361406 A1, Nov. 25, 2021
Int. Cl. A61F 2/04 (2013.01); G01L 1/16 (2006.01); G01L 1/18 (2006.01); G01L 5/101 (2020.01); G01L 5/162 (2020.01); G01N 27/04 (2006.01); A61F 2/48 (2006.01)
CPC A61F 2/04 (2013.01) [G01L 1/16 (2013.01); G01L 1/18 (2013.01); G01L 5/101 (2013.01); G01L 5/162 (2013.01); G01N 27/04 (2013.01); A61F 2002/045 (2013.01); A61F 2/482 (2021.08); A61F 2240/002 (2013.01); A61F 2250/0002 (2013.01); A61F 2250/0096 (2013.01)] 18 Claims
OG exemplary drawing
 
1. A method comprising:
receiving a set of sensor data collected from one or more sensors associated with a bioprinted tissue, wherein the set of sensor data includes chemical concentration data collected by at least one chemical sensor;
analyzing the set of sensor data to determine whether a condition for controlled movement of the bioprinted tissue is met; and
issuing, in response to determining that the condition for controlled movement of the bioprinted tissue is met, a control signal to a set of expansive elements to perform the controlled movement.